abstract |
The present invention relates to polymorphic forms of ( S ) -l-cyanobutan-2-yl ( S ) -1- ( 3 - ( 3 - ( 3 -methoxy-4- ( oxazol-5- yl ) phenyl ) urei do ) phenyl ) ethyl carbamate , pharmaceutical compositions thereof , processes to prepare therein, and uses therewith . |